These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


411 related items for PubMed ID: 19943557

  • 1. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
    Lupei MI, Beilman GJ, Chipman JG, Mann HJ.
    Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
    [Abstract] [Full Text] [Related]

  • 2. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S, Karpati PC, Berton C, Nathan C, Mateo J, Chaara M, Riché F, Laisné MJ, Payen D, Mebazaa A.
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [Abstract] [Full Text] [Related]

  • 3. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD, Jung R, Fish DN, MacLaren R.
    Ann Pharmacother; 2004 May; 38(7-8):1117-22. PubMed ID: 15178740
    [Abstract] [Full Text] [Related]

  • 4. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR, Lam SW, Cha SS, Oyen LJ.
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [Abstract] [Full Text] [Related]

  • 5. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
    Lam SW, Bauer SR, Cha SS, Oyen LJ.
    Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
    [Abstract] [Full Text] [Related]

  • 6. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.
    Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D.
    Crit Care Med; 2006 Mar; 34(3):589-97. PubMed ID: 16505643
    [Abstract] [Full Text] [Related]

  • 7. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
    Bauer SR, Aloi JJ, Ahrens CL, Yeh JY, Culver DA, Reddy AJ.
    J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252
    [Abstract] [Full Text] [Related]

  • 8. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock.
    Mehta NJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR.
    Int J Cardiol; 2004 May; 95(1):13-7. PubMed ID: 15159032
    [Abstract] [Full Text] [Related]

  • 9. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group.
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [Abstract] [Full Text] [Related]

  • 11. Mortality rates under the care of junior and senior surgery residents in a surgical intensive care unit/neurologic intensive care unit: a 5-year retrospective cohort study at Taoyuan Armed Forces General Hospital.
    Lee MT, Hu P, Hsi SC, Liu KY, Chao HM, Chen YQ.
    J Crit Care; 2008 Dec; 23(4):550-5. PubMed ID: 19056021
    [Abstract] [Full Text] [Related]

  • 12. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT, Welage LS, Kraft MD, Alaniz C.
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [Abstract] [Full Text] [Related]

  • 13. Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit.
    Swoboda S, Ober M, Hainer C, Lichtenstern C, Seiler C, Wendt C, Hoppe-Tichy T, Büchler M, Weigand MA.
    J Antimicrob Chemother; 2008 Mar; 61(3):729-33. PubMed ID: 18222953
    [Abstract] [Full Text] [Related]

  • 14. Impact of septic shock hemodynamic resuscitation guidelines on rapid early volume replacement and reduced mortality.
    Permpikul C, Tongyoo S, Ratanarat R, Wilachone W, Poompichet A.
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S102-9. PubMed ID: 20364564
    [Abstract] [Full Text] [Related]

  • 15. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A.
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [Abstract] [Full Text] [Related]

  • 16. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
    Katsaragakis S, Kapralou A, Theodorou D, Markogiannakis H, Larentzakis A, Stamou KM, Drimousis P, Bramis I.
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
    [Abstract] [Full Text] [Related]

  • 17. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL, Walley KR.
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [Abstract] [Full Text] [Related]

  • 19. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
    Sawa N, Ubara Y, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hoshino J, Suwabe T, Uchida N, Wake A, Taniguchi S, Takaichi K.
    Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
    [Abstract] [Full Text] [Related]

  • 20. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
    Jochberger S, Dörler J, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dünser MW.
    Crit Care Med; 2009 Feb; 37(2):476-82. PubMed ID: 19114902
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.